Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

Why Endo International Shares Are Getting Hammered Today

Published 06/05/2022, 14:54
Updated 06/05/2022, 15:43
© Reuters.  Why Endo International Shares Are Getting Hammered Today
ENDPQ
-

Endo International PLC (NASDAQ: ENDP) shares are trading lower by 34.65% at $1.32 after the company reported first-quarter earnings results and issued second-quarter guidance.

Endo International reported quarterly earnings of 66 cents per share which beat the analyst consensus estimate of 44 cents. The company also reported quarterly sales of $652.26 million which beat the analyst consensus estimate of $633.41 million by 3%.

Endo International sees second-quarter sales as low as $500 million or as high as $525 million and adjusted EBITDA as low as $110 million or as high as $125 million. Endo International also sees adjusted EPS in the range of a loss of 15 to 17 cents per share.

See Also: Why DoorDash Shares Are Rising Today

Endo International is a specialty pharmaceutical company with presence in pain management, urology, orthopedics, endocrinology and bariatrics.

According to data from Benzinga Pro, Endo International has a 52-week high of $7.07 and a 52-week low of $1.28.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read at Benzinga

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.